PRO endpoints: 2°

MC Melanie Calvert
MK Madeleine King
RM Rebecca Mercieca-Bebber
OA Olalekan Aiyegbusi
DK Derek Kyte
AS Anita Slade
AC An-Wen Chan
EB E Basch
JB Jill Bell
AB Antonia Bennett
VB Vishal Bhatnagar
JB Jane Blazeby
AB Andrew Bottomley
JB Julia Brown
MB Michael Brundage
LC Lisa Campbell
JC Joseph C Cappelleri
HD Heather Draper
AD Amylou C Dueck
CE Carolyn Ells
LF Lori Frank
RG Robert M Golub
IG Ingolf Griebsch
KH Kirstie Haywood
AH Amanda Hunn
BK Bellinda King-Kallimanis
LM Laura Martin
SM Sandra Mitchell
TM Thomas Morel
LN Linda Nelson
JN Josephine Norquist
DO Daniel O'Connor
MP Michael Palmer
DP Donald Patrick
GP Gary Price
AR Antoine Regnault
AR Ameeta Retzer
DR Dennis Revicki
JS Jane Scott
RS Richard Stephens
GT Grace Turner
AV Antonia Valakas
GV Galina Velikova
MH Maria von Hildebrand
AW Anita Walker
LW Lari Wenzel
request Request a Protocol
ask Ask a question
Favorite

‘If, when reviewing the completed EQ-5D-5L questionnaire, the research nurse becomes concerned for the well-being of the participant, they should discuss their concerns with the participant directly, working in partnership to determine the best course of action. With the participant’s permission, the research nurse may need to consult with the PI and/or treating clinician to address these concerns. In exceptional circumstances, the research nurse may consult with the PI and/or treating clinician without the permission of the participant if they are concerned for the participant’s safety’.

‘If the study research nurse becomes concerned for your well-being during a study review, they will discuss their concerns with you, to determine the best course of action. With your permission, the research nurse may need to consult with a senior member of the study and/or your treating clinician to address these concerns. In exceptional circumstances, the research nurse may need to do this without your prior permission if they are concerned for your safety’.

‘I understand that if the study research nurse becomes concerned for my well-being during a study review, they will discuss their concerns with me to determine the best course of action. With my permission, the research nurse may need to consult with a senior member of the study and/or my treating clinician to address these concerns. In exceptional circumstances, the research nurse may need to do this without my prior permission if they are concerned for my safety.’114

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A